Search Results - "Lavillette D"

This result is not displayed to guests.
Login for full access.

Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer.

Authors: Lin, E.-H. Salon, C. Brambilla, E. et al.

Source: Cancer Gene Therapy. Apr2010, Vol. 17 Issue 4, p256-265. 10p. 1 Diagram, 5 Graphs.

338 IMPACT OF IMMUNE RESTORATION ON NEUTRALIZING ANTIBODIES TO HCV AND QUASISPECIES EVOLUTION IN HIV COINFECTED PATIENTS

Authors: Vaghefi, P. Maurin, G. Lavillette, D. et al.

Source: Journal of Hepatology. Apr2009 Supplement 1, Vol. 50, pS130-S130. 1p.

646 NEUTRALIZATION OF HEPATITIS C IN CHRONICALLY INFECTED SUBJECTS: INFLUENCE OF HIV COINFECTION, LIVER TRANSPLANTATION AND SEVERITY OF LIVER DISEASE

Authors: Maurin, G. Halgand, B. Colman, H. et al.

Source: Journal of Hepatology. Apr2010 Supplement 1, Vol. 52, pS252-S253. 0p.

398 HUMORAL NEUTRALIZING RESPONSE TO HCV DURING HIV COINFECTION AND LIVER TRANSPLANTATION

Authors: Maurin, G. Roque-Afonso, A.-M. Vaghefu, P. et al.

Source: Journal of Hepatology. Apr2009 Supplement 1, Vol. 50, pS151-S151. 1p.

[68] INSIGHTS IN HCV PERSISTENCE: IDENTIFICATION OF VIRAL AND CELLULAR FACTORS THAT DESENSITISE THE NEUTRALISING ANTIBODY RESPONSE AGAINST HCV AND FAVOUR ITS IMMUNE ESCAPE

Authors: Dreux, M. Bartosch, B. Granier, C. et al.

Source: Journal of Hepatology. Apr2007, Vol. 46, pS31-S31. 1p.

P.197 Baseline neutralizing responses predict the virological response to pegylated interferon alpha-ribavirin combination therapy

Authors: Woerther, P. Morice, Y. Barbotte, L. et al.

Source: Journal of Clinical Virology. Jul2006 Supplement 2, Vol. 36 Issue s2, pS121-S122. 0p.

O.171 HDL inhibits HCV neutralisation by CD81-NOB antibodies by stimulating cell entry through activation of the scavenger receptor BI

Authors: Dreux, M. Peitschmann, T. Granier, C. et al.

Source: Journal of Clinical Virology. Jul2006 Supplement 2, Vol. 36 Issue s2, pS52-S53. 0p.

O.192 Scavenger receptor class B type I is a co-receptor for infection with cell culture-derived hepatitis C virus

Authors: Zeisel, M.B. Schnober, E.K. Haberstroh, A. et al.

Source: Journal of Clinical Virology. Jul2006 Supplement 2, Vol. 36 Issue s2, pS58-S58. 1p.

O.137 HDL inhibits neutralisation by HCV antibodies via a ternary interaction with the scavenger receptor BI

Authors: Dreux, M. Pietschmann, T. Granier, C. et al.

Source: Journal of Clinical Virology. Jul2006 Supplement 2, Vol. 36 Issue s2, pS42-S42. 1p.

Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2.

Authors: Yu S Zheng X Zhou Y et al.

Source: PLoS pathogens [PLoS Pathog] 2023 Nov 10; Vol. 19 (11), pp. e1011789. Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement.

Authors: Zhao F Xu Y Liu N et al.

Source: The EMBO journal [EMBO J] 2023 Mar 15; Vol. 42 (6), pp. e112096. Date of Electronic Publication: 2023 Feb 03.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE

A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy.

Authors: Meng L Zha J Zhou B et al.

Source: PLoS pathogens [PLoS Pathog] 2023 Jan 27; Vol. 19 (1), pp. e1011085. Date of Electronic Publication: 2023 Jan 27 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein.

Authors: Xu S Wang Y Zhang C et al.

Source: Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 351-367.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN: 2222-1751 (Electronic) Linking ISSN: 22221751 NLM ISO Abbreviation: Emerg Microbes Infect Subsets: MEDLINE

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.

Authors: Xiong R Zhang L Li S et al.

Source: Protein & cell [Protein Cell] 2022 Oct; Vol. 13 (10), pp. 778.

Publication Type: Published Erratum

Journal Info: Publisher: Oxford University Press Country of Publication: Germany NLM ID: 101532368 Publication Model: Print Cited Medium: Internet ISSN: 1674-8018 (Electronic) Linking ISSN: 1674800X NLM ISO Abbreviation: Protein Cell Subsets: MEDLINE; PubMed not MEDLINE

Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.

Authors: Li T Cai H Yao H et al.

Source: Nature communications [Nat Commun] 2022 Jul 27; Vol. 13 (1), pp. 4359. Date of Electronic Publication: 2022 Jul 27.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant.

Authors: Zang J Yin Y Xu S et al.

Source: Frontiers in immunology [Front Immunol] 2022 Jun 30; Vol. 13, pp. 908478. Date of Electronic Publication: 2022 Jun 30 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody.

Authors: Li T Cai H Zhao Y et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2021 Dec 07; Vol. 13 (12), pp. e14544. Date of Electronic Publication: 2021 Nov 17.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.

Authors: Li T Cai H Yao H et al.

Source: Nature communications [Nat Commun] 2021 Jul 30; Vol. 12 (1), pp. 4635. Date of Electronic Publication: 2021 Jul 30.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2.

Authors: Yao H Cai H Li T et al.

Source: PLoS pathogens [PLoS Pathog] 2021 Mar 03; Vol. 17 (3), pp. e1009328. Date of Electronic Publication: 2021 Mar 03 (Print Publication: 2021).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE